Tower Research Capital LLC (Trc) Decibel Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.41 - $4.81 $5,364 - $10,707	-2,226 Reduced 43.71%	2,867 $11,000
Q1 2023 May 09, 2023	SELL	$2.08 - $4.79 $10,160 - $23,399	-4,885 Reduced 48.96%	5,093 $15,000
Q4 2022 Feb 10, 2023	SELL	$1.86 - $3.54 $3,199 - $6,088	-1,720 Reduced 14.7%	9,978 $20,000
Q3 2022 Nov 10, 2022	BUY	$3.82 - $5.61 $42,333 - $62,170	11,082 Added 1799.03%	11,698 $41,000
Q2 2022 Aug 15, 2022	SELL	$1.85 - $4.21 $144 - $328	-78 Reduced 11.24%	616 $2,000

Q1 2022 May 12, 2022	SELL	$2.83 - $5.03 $2,023 - $3,596	-715 Reduced 50.75%	694 $2,000
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $6,439 - $12,089	1,409 New	1,409 $7,000
Q2 2021 Aug 16, 2021	SELL	$6.39 - $11.51 $7,776 - $14,007	-1,217 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $12,851 - $24,218	1,217 New	1,217 $14,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.